Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jessica K. Anderson"'
Autor:
Peter J. Elliott, Owen A. O'Connor, Stephanie Stahl, Steven L. Soignet, Robert Z. Orlowski, Julian Adams, Natalie D. Depcik-Smith, Roberto Guerciolini, Steven C. Novick, Mary Jo Lehman, Jessica K. Anderson, Christine S. Pien, Thomas E. Stinchcombe, Beverly S. Mitchell, Albert S. Baldwin, Dixie Lee Esseltine, Thomas C. Shea, Rita Bhagat
Publikováno v:
Journal of Clinical Oncology. 20:4420-4427
PURPOSE: To determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacodynamics (PD) of the proteasome inhibitor bortezomib (previously known as PS-341) in patients with refractory hematologic malignancies. PATIENTS AND MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f17e103047888bf8c484868879fdb90e
https://doi.org/10.1200/jco.2002.01.133
https://doi.org/10.1200/jco.2002.01.133
Autor:
Julie Lekstrom-Himes, Grace E. Kim, Karen Daniel, Cheryl Larrivee-Elkins, Suellen White, Michael J. Cima, Neal Shore, Dennis Giesing, Jessica K. Anderson, J. Curtis Nickel, Pankaj Jain, Heejin Lee
Publikováno v:
Science translational medicine. 4(143)
Limited treatment options exist for patients who suffer from a painful bladder condition known as interstitial cystitis/bladder pain syndrome (IC/BPS). Whether given systemically (orally) or by short-duration (1 to 2 hours) exposure via intravesical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d97a5dbe7f12417134757f9b0188fe
https://pubmed.ncbi.nlm.nih.gov/23663606
https://pubmed.ncbi.nlm.nih.gov/23663606
Autor:
Leonard T. Heffner, Sundar Jagannath, Edmund K. Waller, Claire Torre, Robert Z. Orlowski, David P. Schenkein, Paul G. Richardson, David L. Jaye, James R. Berenson, Seema Singhal, Cynthia R. Giver, Jessica K. Anderson, Dixie Lee Esseltine, Sara Giusti, Kenneth C. Anderson, Hugh Xiao, Dixil Francis, Bart Barlogie, S. Lonial
Publikováno v:
Blood. 106(12)
Bortezomib, a proteasome inhibitor with efficacy in multiple myeloma, is associated with thrombocytopenia, the cause and kinetics of which are different from those of standard cytotoxic agents. We assessed the frequency, kinetics, and mechanism of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c7b0e69c02af491c32437cf9f60cc3
https://pubmed.ncbi.nlm.nih.gov/16099887
https://pubmed.ncbi.nlm.nih.gov/16099887